NASDAQ: BCTX
Briacell Therapeutics Corp Stock Ownership - Who owns Briacell Therapeutics?

Insider buying vs selling

Have Briacell Therapeutics Corp insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when BCTX insiders and whales buy or sell their stock.

BCTX Shareholders

What type of owners hold Briacell Therapeutics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Marc Lustig47.90%4,182,935$12.59MInsider
Jamieson Bondarenko1.95%169,856$511.27kInsider
Williams V. Williams1.71%149,636$450.40kInsider
Vaughn C. Embropantalony0.11%9,524$28.67kInsider
Gadi Levin0.03%2,810$8.46kInsider
Martin E. Schmieg0.01%575$1.73kInsider
Cabcar0.00%217$653.17Institution
Cable Car Capital LP0.00%216$650.16Institution
Sabbym0.00%81$243.81Institution
Sabby Management LLC0.00%80$240.80Institution

1 of 5

BCTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BCTX0.01%51.71%
BYSI0.01%11.15%
AARD0.04%46.39%Net SellingNet Selling
FLNA0.03%76.45%Net BuyingNet Buying
RNAZ0.00%22.26%

Briacell Therapeutics Stock Ownership FAQ

Who owns Briacell Therapeutics?

Briacell Therapeutics (NASDAQ: BCTX) is owned by 0.01% institutional shareholders, 51.71% Briacell Therapeutics insiders, and 48.29% retail investors. Marc Lustig is the largest individual Briacell Therapeutics shareholder, owning 4.18M shares representing 47.90% of the company. Marc Lustig's Briacell Therapeutics shares are currently valued at $13.34M.

If you're new to stock investing, here's how to buy Briacell Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.